OTCMKTS:CNTMF Cansortium (CNTMF) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free CNTMF Stock Alerts $0.19 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.19▼$0.2050-Day Range$0.16▼$0.2552-Week Range$0.06▼$0.29Volume327,573 shsAverage Volume358,645 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Cansortium alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About Cansortium Stock (OTCMKTS:CNTMF)Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Miami, Florida.Read More CNTMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNTMF Stock News HeadlinesApril 30, 2024 | msn.comCansortium reports Q4 resultsApril 30, 2024 | msn.comCansortium Revenue Grows In 2023 Thanks To Florida, Net Loss DeclinesMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 30, 2024 | finanznachrichten.deCansortium Inc: Cansortium Reports Fourth Quarter and Full Year 2023 ResultsApril 30, 2024 | finance.yahoo.comCansortium Inc (CNTMF) Q4 2023 Earnings Call Transcript Highlights: Strategic Expansions and ...April 29, 2024 | globenewswire.comCansortium Reports Fourth Quarter and Full Year 2023 ResultsApril 25, 2024 | globenewswire.comCansortium Schedules Fourth Quarter 2023 Conference Call for Monday, April 29 at 4:30 P.M. ETApril 20, 2024 | seekingalpha.comMSOS: 4/20 Is Cannabis Day - Significant Implications For InvestorsMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 7, 2024 | stockhouse.comFlorida's Premier Medical Marijuana Provider FLUENT(TM) Expands with New Dispensary in Daytona BeachApril 5, 2024 | finance.yahoo.comFlorida's Premier Medical Marijuana Provider FLUENT™ Expands with New Dispensary in Daytona BeachApril 2, 2024 | benzinga.comChart: Is The Rise In Florida Centric Cannabis Stock Prices Overdone? (Probably Not!)March 13, 2024 | globenewswire.comFLUENT Prioritizes Reinvestment into Florida-Based Cultivation Facilities with Multiple Renovations and ExpansionsFebruary 6, 2024 | finance.yahoo.comCansortium Announces Shares for Debt SettlementJanuary 22, 2024 | finance.yahoo.comFLUENT Opens 34th Medical Cannabis Dispensary in Cocoa, Florida; 37th NationwideNovember 30, 2023 | msn.comCansortium GAAP EPS of -$0.01, revenue of $25.3MNovember 29, 2023 | finance.yahoo.comCansortium Reports Third Quarter 2023 ResultsNovember 10, 2023 | finance.yahoo.comCansortium Reschedules Third Quarter 2023 Conference Call for Wednesday, November 29 at 4:30 P.M. ETNovember 6, 2023 | finance.yahoo.comCansortium Schedules Third Quarter 2023 Conference Call for Monday, November 13 at 4:30 P.M. ETOctober 23, 2023 | markets.businessinsider.comCannabis Industry Sales Trends: Is Momentum Building or Slowing? A State-By-State Analysis For 3Q23October 4, 2023 | benzinga.comCansortium Stock (OTC:CNTMF) Earnings Dates and Earning CallsAugust 29, 2023 | benzinga.comVertical Integration Pays Off For This Cannabis Company In Q2 2023, Here's WhyAugust 29, 2023 | finanznachrichten.deCansortium Inc: Cansortium Reports Second Quarter 2023 ResultsAugust 28, 2023 | finance.yahoo.comCansortium Reports Second Quarter 2023 ResultsAugust 24, 2023 | finanznachrichten.deCansortium Inc: Cansortium Announces Results of Annual General and Special Meeting of ShareholdersAugust 21, 2023 | finance.yahoo.comCansortium Schedules Second Quarter 2023 Conference Call for Monday, August 28 at 4:30 P.M. ETJuly 21, 2023 | finanznachrichten.deCansortium Inc: Cansortium Appoints John Mazarakis to its Board of DirectorsSee More Headlines Receive CNTMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cansortium and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:CNTMF CUSIPN/A CIKN/A Webwww.cansortium.com Phone(305) 441-9085FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. William M. SmithExecutive ChairmanMr. Robert BeasleyCEO & DirectorMs. Samantha Senne HymesExecutive Vice President of OperationsMr. Victor BindiDirector of SalesMs. Liora BoudinCorporate ControllerMr. Jeffrey Robert Batliner (Age 59)Chief Financial Officer Dr. Jennifer McCafferty-FernandezChief Science OfficerMr. Jeffrey ReathConsultantMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors CNTMF Stock Analysis - Frequently Asked Questions How have CNTMF shares performed in 2024? Cansortium's stock was trading at $0.0890 at the start of the year. Since then, CNTMF stock has increased by 113.5% and is now trading at $0.19. View the best growth stocks for 2024 here. Are investors shorting Cansortium? Cansortium saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 39,800 shares, an increase of 25.2% from the March 31st total of 31,800 shares. Based on an average trading volume of 1,189,000 shares, the short-interest ratio is presently 0.0 days. View Cansortium's Short Interest. How do I buy shares of Cansortium? Shares of CNTMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CNTMF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Gold Grab of the CenturyColonial Metals4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cansortium Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.